Endocrinology India

Search CTRL + K

Endocrinology India

Search CTRL + K
About Us
About us →
Dr. Om J Lakhani
AI Corner
AI Corner →
Prompt for Diagnosing a Clinical Image
Prompt of academic medical research using Perplexity
Prompts for Generating Summary
The Chen-Gui Tool
Vivien Thomas Tool
BOOK SERIES
Our Books →
Volume 1- THE BEST OF NOTES IN ENDOCRINOLOGY BOOK SERIES
Volume 2- THE BEST OF NOTES IN ENDOCRINOLOGY - DIABETES SPECIAL
Creativity
Creativity →
Meet an Endocrinologist
Endocrinologist ToolKit
Adrenal Insufficiency Diagnostic Calculator using DHEAS based on Han Suresh et al
Body Roundness Index Calculator
Diabetes remission tool
Fib-4 Calculator
Garg-Memon Tool
Insulin dose Calculator
Liu-Hao Tool
Liver disease classifier
ToolKit for Endocrinologists →
Which insulin to initiate ?
Human-in-Loop research
Does the TSH increase in Winters ?
Duration of Octreotide Therapy in Acromegaly
Fluoroquinolones and Dysglycemia- A Clinical Overview
How ancient philosophy led to modern day AI
How are People using AI in 2025 ?
Human-in-Loop Research →
Metaphyseal Chondrodysplasia, Schmid Type (MCDS)
Quantum Computing in Healthcare- A New Frontier
What is the role of 68Ga-Pentixafor PET-CT - CXCR4 PET scan in Primary aldosteronism ?
What is the role of MRI in Thyroid-Associated Orbitopathy (TAO) ?
What is the role of Prasugrel in Diabetes Mellitus ?
Misc
Online Consultation →
Notes in Endocrinology
ABSTRACTS OF IMPORTANT TRIALS
IRIS trial
PROactive study
ADRENAL GLAND
Adrenal insufficiency
Adrenal insufficiency in Critical illness
Adrenal insufficiency in exogenous non oral corticosteroid use
Causes of Primary Adrenal insufficiency in Adults
Clinical features of adrenal insufficiency in adults
Diagnosis of Adrenal insufficiency
Treatment of Adrenal insufficiency
Cushing syndrome
Exogenous Cushing syndrome (Iatrogenic Cushing syndrome)
Pheochromocytoma
Genetics of Pheochromocytoma & Paraganglioma
Physiology and pharmacology of glucocorticoids
An overview of the pharmacological uses of Glucocorticoids
Glucocorticoid induced osteoporosis (GIO)
Glucocorticoid-induced osteonecrosis (Avascular necrosis)
Major side effects of systemic glucocorticoids
BONE AND MINERAL DISORDERS
ENDOCRINOLOGY OF VITAMIN D
Evaluation and treatment of Vitamin D deficiency
Non-Calciotropic actions of Vitamin D
Physiology and Metabolism of Vitamin D
Vitamin D beyond bones- was it all just a hype- Balanced view of current status
Vitamin D toxicity
OSTEOPOROSIS
Management of Osteoporosis in postmenopausal women
Post-transplant osteoporosis
Romosozumab
Screening and diagnosis of Osteoporosis
Other Metabolic bone disease
Fibrous Dysplasia
Renal tubular acidosis
Metabolic bone disorder in CKD (CKD-MBD)
DIABETES
ANATOMY AND PHYSIOLOGY OF THE PANCREAS
Non-alcoholic fatty pancreas disease
Normal Islet cell and Beta-cell structure and function
Secretion of insulin and regulation of insulin secretion
CHRONIC COMPLICATIONS OF DIABETES
DIABETIC RETINOPATHY
Diabetic macular edema
Frozen shoulder (adhesive capsulitis)-- in patients with diabetes mellitus
Pathogenesis of microvascular complications in diabetes
CLASSIFICATION, DIAGNOSIS AND OTHER FORMS OF DIABETES
Blood glucose monitoring
C-peptide
Cystic fibrosis related diabetes
Fibrocalculous pancreatic diabetes
Glycated hemoglobin (HbA1c)
Latent autoimmune diabetes of Adulthood (LADA)
Monogenic diabetes- MODY (Maturity onset of Diabetes of Young) & Neonatal Diabetes
DIABETES AND DERMATOLOGY
Acanthosis Nigricans
DIABETES AND INFECTIOUS DISEASES
Mucormycosis and Diabetes
Susceptibility for infection in diabetes mellitus
DIABETES AND KIDNEY
Finerenone for Diabetic kidney disease
Management of Diabetes in patients with CKD
Nephron protection in Diabetic kidney disease
Overview of the management of diabetic kidney disease
Updates on Management of Diabetic kidney disease
DIABETES AND NERVOUS SYSTEM
Treatment of Diabetic Neuropathy
DIABETES AND OTHER SYSTEMS
Sleep disorders and Diabetes
DIABETES AND THE CARDIOVASCULAR SYSTEM
Diabetic Dyslipidemia
Heart Failure in Diabetes, non coronary cardiac complications in diabetes and diabetic cardiomyopathy
Insulin and the Cardiovascular system
DIABETES IN PREGNANCY
Metformin in pregnancy
HYPOGLYCEMIA
Definition and Physiology of Hypoglycemia
Hypoglycemia in adults without diabetes mellitus
Hypoglycemia in patients with diabetes mellitus
Insulin autoimmune syndrome
NICTH (Non Islet cell Tumor hypoglycemia) & IGF-2 related hypoglycemia
Nocturnal hypoglycemia
Sulphonylurea induced hypoglycemia
MANAGEMENT OF DIABETES IN SPECIAL CIRCUMSTANCES
Diabetes in the elderly
In-hospital hyperglycemia management for COVID-19 patients on Steroids
Management of diabetes mellitus during Ramadan
Newer therapies for Diabetes management
Diabetes Remission
Once weekly insulin - Insulin icodec & more
Pancreatic & Islet cell transplantation
Precision medicine in Diabetes
Teplizumab in Type 1 Diabetes
PATHOGENESIS OF TYPE 1 DIABETES
Pathogenesis of Type 1 Diabetes
PATHOGENESIS OF TYPE 2 DIABETES
Insulin resistance
1.0 Insulin resistance- Introduction, Definition and Quantification
2.0 Mechanisms for Insulin Resistance
3.0 Clinical features of Insulin resistance
Disorders of Severe insulin resistance (including detailed discussion on Type B insulin resistance)
Glucose Toxicity (Glucotoxicity)
Mechanism of beta-cell dysfunction in T2DM
Pathogenesis of Type 2 Diabetes in Indian Population
PHARMACOTHERAPY IN DIABETES MANAGEMENT
General principles of Insulin therapy
Imeglimin
Lobeglitazone
Mathematics of Insulin dosing
Perioperative use of SGLT2 inhibitors
Pharmacoeconomics
Verapamil in Diabetes with special reference to it's use in Type 1 Diabetes
ENDOCRINE ONCOLOGY
NEUROENDOCRINE TUMORS
Carcinoid syndrome
Neuroendocrine tumor markers
Endocrinology of childhood cancer survivors
FEMALE REPRODUCTIVE ENDOCRINOLOGY
Female Infertility
Female infertility - Etiology
Female infertility - Evaluation
Female Infertility and Thyroid dysfunction
Overview of Female Infertility
Overview of the treatment of female infertility
Ovulation Induction
Menopause
Menopause and Menopause hormonal therapy
Other topics in Female Reproductive endocrinology
Evaluation of the timing of ovulation in a menstrual cycle
Hypothalamic amenorrhea
Menstrual history and Endocrinology
Premenstrual syndrome and premenstrual dysphoric disorder
Ultrasound evaluation of the normal menstrual cycle
PCOS
Clinical manifestations of polycystic ovary syndrome in adults
Diagnosis of PCOS
Management of PCOS
Pathogenesis of PCOS
AMH
Endometriosis
Fibroids
Non-classical CAH
Premature ovarian insufficiency (POI)
Secondary amenorrhea
MALE REPRODUCTIVE ENDOCRINOLOGY
MALE HYPOGONADISM
Androgens and Cardiovascular disease in men
Causes of hypogonadism in males
Clinical features and diagnostic approach to Male hypogonadism
Genetics of Idiopathic hypogonadotropic hypogonadism
Idiopathic hypogonadotropic hypogonadism in boys
Klinefelter syndrome
Treatment of Secondary Hypogonadism and Idiopathic hypogonadotropic hypogonadism in Men
MALE INFERTILITY
Azoospermia
Etiology of Male infertility
Male infertility- Other points
Outline of the Management of Male infertility
Semen analysis
Semen Cryopreservation
MISC ENDOCRINOLOGY
ENDOCRINE DISORDERS IN PREGNANCY
Diagnosis and management of gestational hyperandrogenism
MULTISYSTEM ENDOCRINE DISORDERS
Asymptomatic Hyperuricemia
Endocrine dysfunction with the use of Proton pump inhibitors
Clinical manifestations and management of hypokalemia
Endocrinology of Love
NIE InstaReview
Role of Inhibin B, AMH, GnRHa Test, and HCG Stimulation Test to Distinguish Isolated Hypogonadotropic Hypogonadism (IHH) from Constitutional Delay in Growth and Puberty (CDGP)
SGLT2 inhibitor in Ketosis prone type 2 diabetes (NIE InstaReview 1)
SNAC
STEP-HFpEF DM Trial
Survodutide in MASH
Tramadol-Induced Adrenal Insufficiency
Waist to height ratio
OBESITY & METABOLIC SYNDROME
Evidence based diets in Endocrinology
Mechanisms of Weight loss after Obesity surgery
NASH-NAFLD
OBESITY – ETIOLOGY, EVALUATION AND NATURAL HISTORY
Pharmacological management of Obesity
Resmetirom and Hepatic hypothyroidism
PEDIATRIC ENDOCRINOLOGY
Disorder of Sexual differentiation
Disorder of sexual differentiation (DSD)- Classification and Etiology
Puberty
Delayed puberty in boys
Turner syndrome
SHORT STATURE AND GROWTH HORMONE
Treatment of Growth hormone deficiency in Children
PITUITARY GLAND
Aggressive pituitary tumor (Atypical pituitary tumor) and Pituitary carcinoma
Familial isolated pituitary adenoma (FIPA)
Pituitary apoplexy
TECHNOCRINOLOGY
Artificial intelligence in Medicine
Insulin algorithm
THYROID
Clinical features of Hypothyroidism
Hashimoto's encephalopathy
Hypothyroidism and Hair loss
Neuropsychiatric manifestations of Hypothyroidism
Management of hypothyroidism
Refractory hypothyroidism
Subclinical hypothyroidism
T3 (Liothyronine)
The Normal Thyroid gland
Iodine deficiency disorders
THYROID (miscellaneous topics)
Anticancer drug induced thyroid dysfunction
Perioperative management of Non-thyroidal surgery in thyroid dysfunction
Thyroid disorders in Pregnancy
1. Overview of thyroid disease in pregnancy
2. Hypothyroidism in pregnancy
3. Maternal Thyroid function and the fetal brain development
3. Thyrotoxicosis in Pregnancy
THYROID NODULE & THYROID CANCER
Diagnostic approach to Thyroid nodule
Thyrotoxicosis
1. Etiology of Thyrotoxicosis
2. Diagnostic Approach to patient with Thyrotoxicosis
Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)
Pathogenesis of Graves' disease
Pharmacology of Anti-thyroid drugs
Thyroid storm
Notes in Endocrinology →
Patient information
Can Diabetes be reversed ? The truth about Diabetes remission (not Reversal)
How does Ezetimibe work ?
How to the 21-day pill pack for PCOS ? (like DIANE or KRIMSON)
Is my hair loss because of my thyroid problem ?
Metformin in Pregnancy- What You Need to Know
Patient information →
The better marker for Obesity- The BRI
The Story of a Plaque- from Cholesterol to a heart attack
Understanding Fibrocalculous Pancreatic Diabetes (FCPD)
Understanding LINORMA T3 (Liothyronine)
Understanding Pituitary Apoplexy
What causes Gestational Diabetes during pregnancy?
Who is an Endocrinologist ?
Presentation Library
Diabetes Remission presentation
Presentation Library →
Wearable Technology for Healthcare professionals
Research Summary
Can you use MRI to predict response to steroid in TAO ?
DHEAS for Diagnosis of Adrenal Insufficiency
Diagnosis of Cushing syndrome in patients with chronic kidney disease
Differentiating CDGP from IHH
Does positive RF factor interfere with TSH value ?
Experience with Pituitary Apoplexy from India
Glycated GD59
How does Body Roundness Index correlate with mortality risk ?
Insulin resistance & Atherosclerosis
Is BMD enough for assessment of osteoporosis in post-menopausal women with diabetes ? The role of TBS
MRI STIR sequence for Disease activity in TAO
New Radiotracer for Primary hyperparathyroidism
Radiotherapy in Painful Osteoarthritis
Research Summary →
Role of FDG-PET in Characterizing Adrenal Mass Lesions
Screening for Primary Aldosteronism without stopping antihypertensive medications
Ultrasound-Guided Glenohumeral Corticosteroid Injection for the Treatment of Adhesive Capsulitis of the Shoulder The Role of Clinical Stage in Response to Treatment
Using Dapagliflozin for Diabetes Remission
What is the role of Empagliflozin in MASLD ?
Support us
DONATION
Support us →
YouTube Channel
YouTube Channel →
Homepage
Enter to select
to navigate
ESC to close
  • Credits

    • Section Writer: Dr. Om J Lakhani
    • Section Editor: Dr. Om J Lakhani
  • **Induction of fertility in males with secondary hypogonadism **

  • Q. What are the factor that influences fertility in males with secondary hypogonadism?

    • Bilateral cryptorchidism or unilateral – with no spontaneous descent my one year – reduces the chances
    • Larger the size, of testis-better the response
    • Hypo hypo after puberty have a better response than those before puberty
    • Partial hypogonadism – better response than complete hypogonadism
    • Prior treatment with Testosterone reduces chances for fertility
  • **Gonadotropin therapy **

  • Q. Describe the current protocol used for management of fertility using gonadotropins for patients with hypogonadotropic hypogonadism at Zydus hospital

    • Baseline assessment
      • Testicular volume
      • SPL
      • FSH
      • LH
      • Testosterone
      • Inhibin B
      • Bone age
    • If TV < 4 ml with/without Inhibin B <60 pg/ml +/- Cryptorchidism
      • Start with HMG 150 IU three times a week
      • After 2 months
        • Repeat Inhibin B
        • FSH
      • If FSH 4-8 IU/l , TV >4 ml has improved, and Inhibin B is >60 pg/ml, then add HCG
      • If the patient has symptoms of Hypogonadism- Testosterone may be temporarily added
    • If TV >4 ml / Acquired hypogonadism , Inhibin B >60 , No cryptorchidism
      • Start with HCG 1500 IU twice a week and HMG 75 IU twice a week
      • Add Letrozole 2.5 mg daily
      • After 6 weeks
        • TV
        • FSH
        • Testosterone - done on day 4 after last HCG dose - repeat every 6 weeks till in normal range
        • Hemoglobin
      • Titrate the dose of HCG to achieve
        • Normal T levels
        • No Erythrocytosis
      • Titrate HMG to achieve
        • FSH value of 4-8 IU/ml
    • When to take semen analysis
      • Start Semen analysis once the TV is 8 ml
      • After 2-3 days of abstinence
      • Repeat every 2-3 weeks
      • Once sperm count is good, consider cryopreservation of sperm, after which the patient may be shifted to HCG alone
  • Q. Can LH/HCG alone stimulate spermatogenesis?

    • It often does due to improvement in intratesticular testosterone
  • Q. Is recombinant LH better than HCG?

    • No
    • HCG is good enough
    • Recombinant LH has a shorter half-life than HCG and hence needs to be given daily
    • Also, it is more expensive
  • Q. How is HCG given- subcutaneously or intramuscularly?

    • It is recommended to be used IM
    • However, it can be given subcutaneously (though not approved for this route)
  • Q. What is the starting dose for HCG?

    • 1500-2000 IU intramuscularly twice/three times a week – Mon, Wed, Friday
  • Q. How is monitoring done with HCG treatment?

    • Testosterone is measured every 1-2 months
    • It is kept in the range of 400-800 ng/dl
    • If this range is not achieved, increased the dose of HCG
    • If dose >10,000 IU- 3 times a week –then think of anti HCG antibodies
  • Q. When to start measuring the sperm count?

    • Sperm count is measured after testosterone has been in the normal range of 400-800 ng/dl
    • Semen analysis can be done every 1-2 months
    • However, semen analysis must not be used to determine response to therapy
  • Q. How much sperm count do we target?

    • 5-10 million / ml
  • Q. How much time does it take to achieve this sperm count?

    • 6 months  - 24 months!
  • Q. When is HMG / FSH added?

    • If the sperm count is <5 million/ml even though testosterone has been normal for >6months
    • Then add HMG/FSH
    • Recently, experts recommend starting FSH/HMG early
  • Q. FSH is required for initiation or maintenance of spermatogenesis?

    • Spermatogenesis is initiated by FSH but probably not required for maintenance
  • Q. How does FSH impact spermatogenesis?

    • It impacts spermatogenesis via its action of Sertoli cells
  • Q. What is the starting dose of HMG used?

    • 75 Units three times a week – can be given in the same syringe as HCG
  • Q. How is monitoring done once on HMG?

    • Monitor Sperm count every 1-2 months
    • Sperm counts fluctuate, so look for a trend
  • Q. When is the dose of HMG increased?

    • It is increased to 150 units if the sperm count remains <5 million/ml after 6 months
  • Q.. Is it worthwhile to continue HCG / HMG if sperm counts are a few million?

    • Yes
    • Sometimes, this low value can also lead to impregnation
  • Q. What is the advantage of Recombinant FSH (rhFSH)?

    • It is mainly developed for ovulation induction and offers no particular advantage to the patient
    • It has not been head-on compared with HMG, but  extra purity of FSH may not be particularly required
  • Q. What is the meantime to achieving normal sperm count and fertility?

    • Mean to first sperm is 7.1 month
    • Mean to fertility is 28 months!
  • Q. When is ART considered?

    • When pregnancy is not achieved within 12-24 months, ART must be considered
    • Options are Intrauterine insemination, IVF or ICSI (last option)
  • Q. What is done once fertility is achieved?

    • HCG and HMG are continued till 1st trimester of pregnancy
    • After delivery, if the couple plan to conceive again, HCG is continued, and HMG is added when pregnancy is planned
    • If pregnancy is not planned again  - then shift to testosterone or continue HCG
  • Q. What is done for cryptorchidism in CHH patients in infancy?

    • Surgery is done between 6-12 months of age
  • Q. What is done for the micropenis?

    • Testosterone, DHT, or FSH/LH between 1-6 months of age
  • Q. Can FSH given during infancy induce spermatogenesis?

    • No
    • It cannot
    • Because Sertoli cells are not affected as they do not have androgen receptors in childhood
    • Androgen receptors of Sertoli cells develop after five years of age
  • Q. How is testosterone therapy initiated or maintained in a child with hypo hypo?

    • Start with a low dose of 50 mg
    • Gradually increase to full adult dose over 2 years
  • Q. A child on testosterone therapy has an increase in the size of the testis. What does it indicate?

    • Testosterone does not increase the size of the testis
    • So, if the testis size has increased, it suggests a spontaneous reversal of the disease and hence stop testosterone and re-evaluate the HPG axis
  • Q. Describe the GnRH pump therapy

    • GnRH is administered 24 hours a day (even during sleeping and bathing) at 90-minute intervals through a pump with a needle, which is introduced under the skin of the abdomen (subcutaneous). The pump can also be attached via a thin hose into a vein in the lower arm (intravenous). The pump is the most significant disadvantage of the treatment.
  • Q. Give the protocol for GnRH administration?

    • It is injected using a pump
    • IV is preferred to subcutaneous
    • A pulse is given every 60-90 min
    • Dose is 2.5-5 mcg per pulse